Literature DB >> 2695222

MRI studies of atherosclerotic vascular disease: structural evaluation and physiological measurements.

R H Mohiaddin, D B Longmore.   

Abstract

The widespread prevalence of atherosclerotic vascular disease has given rise to the need for a noninvasive imaging examination. Magnetic resonance imaging has been shown to allow assessment of early arterial disease non-invasively and without the use of ionising radiation. Arterial compliance, pulse wave velocity, and the pattern of flow within the aorta may all be disturbed by disease and these parameters can be measured by magnetic resonance. In addition, atheroma can be imaged directly, its size measured, its shape described, its lipid content assessed, and its effects upon vascular haemodynamics studied. Magnetic resonance imaging is thus a potential tool not only for the detection of disease but also for studying its natural history and the effects of interventions, such as the control of risk factors and of lipid lowering agents.

Entities:  

Mesh:

Year:  1989        PMID: 2695222     DOI: 10.1093/oxfordjournals.bmb.a072377

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  3 in total

Review 1.  Quantitative evaluation of carotid atherosclerotic plaques by magnetic resonance imaging.

Authors:  Chun Yuan; Xue-Qiao Zhao; Thomas S Hatsukami
Journal:  Curr Atheroscler Rep       Date:  2002-09       Impact factor: 5.113

Review 2.  Review of MRI-based measurements of pulse wave velocity: a biomarker of arterial stiffness.

Authors:  Andrew L Wentland; Thomas M Grist; Oliver Wieben
Journal:  Cardiovasc Diagn Ther       Date:  2014-04

3.  Spironolactone Reduces Aortic Stiffness in Patients With Resistant Hypertension Independent of Blood Pressure Change.

Authors:  Sudeep R Aryal; Mohammed Siddiqui; Oleg F Sharifov; Megan D Coffin; Bin Zhang; Krishna K Gaddam; Himanshu Gupta; Thomas S Denney; Louis J Dell'Italia; Suzanne Oparil; David A Calhoun; Steven G Lloyd
Journal:  J Am Heart Assoc       Date:  2021-08-28       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.